Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlook
1College of Medicine, Institute of Behavioral Medicine, National Cheng Kung University, Tainan, Taiwan.
Abstract:
Mild cognitive impairment (MCI) is one of the common non-motor symptoms in patients with Parkinson's disease (PD). MCI is the transition stage between normal aging and full-blown dementia and is also a powerful predictor of dementia. Although the concept of MCI has been used to describe some of the PD symptoms for many years, there is a lack of consistent diagnostic criteria. Moreover, because of the diverse patterns of the cognitive functions, each cognitive impairment will have a different progression. In this review, we overviewed the diagnostic criteria for PD-MCI, primarily focused on the heterogeneity of PD-MCI patients' cognitive function, including various types of cognitive functions and their progression rates. A review of this topic is expected to be beneficial for clinical diagnosis, early intervention, and treatment. In addition, we also discussed the unmet needs and future vision in this field.
Insights
Parkinson's disease patients often experience mild cognitive impairment (MCI), a precursor to dementia. This review examines diagnostic criteria and cognitive patterns in Parkinson's disease mild cognitive impairment (PD-MCI) to aid early detection and treatment.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) is a common non-motor symptom in Parkinson's disease (PD).
- MCI signifies a transitional stage between normal aging and dementia, acting as a dementia predictor.
- Existing diagnostic criteria for PD-MCI lack consistency, hindering clinical application.
Purpose of the Study:
- To review diagnostic criteria for Parkinson's disease with mild cognitive impairment (PD-MCI).
- To focus on the heterogeneity of cognitive function and progression rates in PD-MCI patients.
- To provide insights for clinical diagnosis, early intervention, and treatment strategies.
Main Methods:
- Literature review of diagnostic criteria for PD-MCI.
- Analysis of cognitive function patterns and progression in PD-MCI.
- Discussion of unmet needs and future research directions in the field.
Main Results:
- Parkinson's disease mild cognitive impairment (PD-MCI) presents diverse cognitive profiles.
- Cognitive impairments in PD-MCI exhibit varied progression rates.
- Inconsistent diagnostic criteria complicate the identification and management of PD-MCI.
Conclusions:
- Standardized diagnostic criteria for PD-MCI are crucial for effective clinical management.
- Understanding cognitive heterogeneity is key for personalized interventions in PD-MCI.
- Further research is needed to address unmet needs and advance the field of PD-MCI.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation
Alzheimer's Disease: Treatment


